The use of statins to prevent postoperative atrial fibrillation after coronary artery bypass grafting: A meta-analysis of 12 studies

Journal of Cardiovascular Pharmacology

Volumn 64, Issue 3, 2014, Pages 285-292

  Zheng, Hui ^a   Xue, Song ^a   Hu, Zhen Lei ^a   Shan, Jiang Gui ^a   Yang, Wen Gang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Arrhythmia therapy; Atrial fibrillation; Coronary artery bypass grafting; Statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS GRAFT; HEART ARRHYTHMIA; HOSPITALIZATION; HUMAN; INCIDENCE; META ANALYSIS (TOPIC); OBSERVATIONAL STUDY; PREOPERATIVE CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REGRESSION ANALYSIS; REVIEW; ADVERSE EFFECTS; LENGTH OF STAY; META ANALYSIS; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATIONS; PROCEDURES;

ATRIAL FIBRILLATION; CORONARY ARTERY BYPASS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INCIDENCE; LENGTH OF STAY; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; REGRESSION ANALYSIS;

EID: 84929939115     PISSN: 01602446     EISSN: 15334023     Source Type: Journal    
DOI: 10.1097/FJC.0000000000000102     Document Type: Review

References (43)

1. Mathew JP, Fontes ML, Tudor IC, et al; Investigators of the Ischemia Research and Education Foundation; Multicenter Study of Perioperative Ischemia Research Group. A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA. 2004; 291: 1720-1729.
2. Creswell LL, Schuessler RB, Rosenbloom M, et al. Hazards of postoperative atrial arrhythmias. Ann Thorac Surg. 1993; 56: 539-549.
3. Aviles RJ, Martin DO, Apperson-Hansen C, et al. Inflammation as a risk factor for atrial fibrillation. Circulation. 2003; 108: 3006-3010.
4. Anselmi A, Possati G, Gaudino M. Postoperative inflammatory reaction and atrial fibrillation: simple correlation or causation? Ann Thorac Surg. 2009; 88: 326-333.
5. Issac TT, Dokainish H, Lakkis NM. Role of inflammation in initiation and perpetuation of AF: a systematic review of the published data. J Am Coll Cardiol. 2007; 50: 2021-2028.
6. Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996; 17: 1-12.
7. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and nonrandomised studies of health care interventions. J Epidemiol Community Health. 1998; 52: 377-384.
8. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21: 1539-1558.
9. Ji Q, Mei Y, Wang X, et al. Effect of preoperative atorvastatin therapy on atrial fibrillation following off-pump coronary artery bypass grafting. Circ J. 2009; 73: 2244-2249.
10. Mannacio VA, Iorio D, De Amicis V, et al. Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial. J Thorac Cardiovasc Surg. 2008; 136: 1541-1548.
11. Song YB, On YK, Kim JH, et al. The effects of atorvastatin on the occurrence of postoperative atrial fibrillation after off-pump coronary artery bypass grafting surgery. Am Heart J. 2008; 156: 373.e9-373.e16.
12. Sun Y, Ji Q, Mei Y, et al. Role of preoperative atorvastatin administration in protection against postoperative atrial fibrillation following conventional coronary artery bypass grafting. Int Heart J. 2011; 52: 7-11.
13. Karimi A, Bidhendi LM, Rezvanfard M, et al. The effect of a high dose of atorvastatin on the occurrence of atrial fibrillation after coronary artery bypass grafting. Ann Thorac Surg. 2012; 94: 8-14.
14. Kinoshita T, Asai T, Nishimura O, et al. Statin for prevention of atrial fibrillation after off-pump coronary artery bypass grafting in Japanese patients. Circ J. 2010; 74: 1846-1851.
15. Mariscalco G, Lorusso R, Klersy C, et al. Observational study on the beneficial effect of preoperative statins in reducing atrial fibrillation after coronary surgery. Ann Thorac Surg. 2007; 84: 1158-1164.
16. Marín F, Pascual DA, Roldán V, et al. Statins and postoperative risk of atrial fibrillation following coronary artery bypass grafting. Am J Cardiol. 2006; 97: 55-60.
17. Miceli A, Fino C, Fiorani B, et al. Effects of preoperative statin treatment on the incidence of postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ann Thorac Surg. 2009; 87: 1853-1858.
18. Ozaydin M, Dogan A, Varol E, et al. Statin use before by-pass surgery decreases the incidence and shortens the duration of postoperative atrial fibrillation. Cardiology. 2007; 107: 117-121.
19. Sakamoto H, Watanabe Y, Satou M. Do preoperative statins reduce atrial fibrillation after coronary artery bypass grafting? Ann Thorac Cardiovasc Surg. 2011; 17: 376-382.
20. Tamura K, Arai H, Ito F, et al. Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation. Gen Thorac Cardiovasc Surg. 2010; 58: 120-125.
21. Haywood LJ, Ford CE, Crow RS, et al, ALLHAT Collaborative Research Group. Atrial fibrillation at baseline and during follow-up in ALLHAT (antihypertensive and lipid-lowering treatment to prevent heart attack trial). J Am Coll Cardiol. 2009; 54: 2023-2031.
22. Frustaci A, Chimenti C, Bellocci F, et al. Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 1997; 96: 1180-1184.
23. Chung MK, Martin DO, Sprecher D, et al. C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation. 2001; 104: 2886-2891.
24. März W, Scharnagl H, Winkler K, et al. Low-density lipoprotein triglycerides associated with low-grade systemic inflammation, adhesion molecules, and angiographic coronary artery disease: the Ludwigshafen Risk and Cardiovascular Health study. Circulation. 2004; 110: 3068-3074.
25. König D, Deibert P, Winkler K, et al. Association between LDLcholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease. Exerc Immunol Rev. 2005; 11: 97-107.
26. Plenge JK, Hernandez TL, Weil KM, et al. Simvastatin lowers C-reactive protein within 14 days: an effect independent of low-density lipoprotein cholesterol reduction. Circulation. 2002; 106: 1447-1452.
27. Peña JM, MacFadyen J, Glynn RJ, et al. High-sensitivity C-reactive protein, statin therapy, and risks of atrial fibrillation: an exploratory analysis of the JUPITER trial. Eur Heart J. 2012; 33: 531-537.
28. Conen D, Tedrow UB, Koplan BA, et al. Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation. 2009; 119: 2146-2152.
29. Lau YF, Yiu KH, Siu CW, et al. Hypertension and atrial fibrillation: epidemiology, pathophysiology and therapeutic implications. J Hum Hypertens. 2012; 26: 563-569.
30. Okin PM, Wachtell K, Devereux RB, et al. Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of newonset atrial fibrillation in patients with hypertension. JAMA. 2006; 296: 1242-1248.
31. Du H, Fan J, Ling Z, et al. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients. Hypertension. 2013; 61: 786-792.
32. Ascione R, Caputo M, Calori G, et al. Predictors of atrial fibrillation after conventional and beating heart coronary surgery: a prospective, randomized study. Circulation. 2000; 102: 1530-1535.
33. Matata BM, Sosnowski AW, Galinanes M. Off-pump bypass graft operation significantly reduces oxidative stress and inflammation. Ann Thorac Surg. 2000; 69: 785-791.
34. Youn JY, Zhang J, Zhang Y, et al. Oxidative stress in atrial fibrillation: an emerging role of NADPH oxidase. J Mol Cell Cardiol. 2013; 62: 72-79.
35. Kim YH, Lim DS, Lee JH, et al. Gene expression profiling of oxidative stress on atrial fibrillation in humans. Exp Mol Med. 2003; 35: 336-349.
36. Reilly SN, Jayaram R, Nahar K, et al. Atrial sources of reactive oxygen species vary with the duration and substrate of atrial fibrillation: implications for the antiarrhythmic effect of statins. Circulation. 2011; 124: 1107-1117.
37. Arsenault KA, Yusuf AM, Crystal E, et al. Interventions for preventing post-operative atrial fibrillation in patients undergoing heart surgery. Cochrane Database Syst Rev. 2013; 1: CD003611.
38. Kulik A, Ruel M. Lipid-lowering therapy and coronary artery bypass graft surgery: what are the benefits? Curr Opin Cardiol. 2011; 26: 508-517.
39. Kulik A, Voisine P, Mathieu P, et al. Statin therapy and saphenous vein graft disease after coronary bypass surgery: analysis from the CASCADE randomized trial. Ann Thorac Surg. 2011; 92: 1284-1290.
40. Kuhn EW, Liakopoulos OJ, Stange S, et al. Meta-analysis of patients taking statins before revascularization and aortic valve surgery. Ann Thorac Surg. 2013; 96: 1508-1516.
41. Baran C, Durdu S, Dalva K, et al. Effects of preoperative short term use of atorvastatin on endothelial progenitor cells after coronary surgery: a randomized, controlled trial. Stem Cell Rev. 2012; 8: 963-971.
42. Mills EJ, Rachlis B, Wu P, et al. Primary prevention of cardiovascular mortality and events with statin treatments: a network meta-analysis involving more than 65, 000 patients. J Am Coll Cardiol. 2008; 52: 1769-1781.
43. Aranki SF, Shaw DP, Adams DH, et al. Predictors of atrial fibrillation after coronary artery surgery. Current trends and impact on hospital resources. Circulation. 1996; 94: 390-397.